Oslo - Delayed Quote NOK
BerGenBio ASA (BGBIO.OL)
1.7880
-0.0300
(-1.65%)
As of 12:52:44 PM GMT+2. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
155,796
174,335
166,706
450,236
Total Liabilities Net Minority Interest
33,095
46,859
78,208
65,809
Total Equity Gross Minority Interest
122,701
127,476
88,498
384,427
Total Capitalization
123,519
127,476
88,773
385,369
Common Stock Equity
122,701
127,476
88,498
384,427
Capital Lease Obligations
--
418
--
681
Net Tangible Assets
122,701
127,476
88,498
384,427
Working Capital
122,266
127,045
88,730
384,177
Invested Capital
123,519
127,476
88,773
385,369
Tangible Book Value
122,701
127,476
88,498
384,427
Total Debt
818
418
275
1,623
Share Issued
39,087.1160
26,886.8920
1,026.9090
1,024.5320
Ordinary Shares Number
39,087.1160
26,886.8920
1,026.9090
1,024.5320
12/31/2021 - 4/7/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SOFTX.OL SoftOx Solutions AS
0.0666
+4.43%
MVIR.ST Medivir AB (publ)
1.5780
-1.38%
LYTIX.OL Lytix Biopharma AS
5.18
-3.72%
ONCO.ST Oncopeptides AB (publ)
1.9240
-1.13%
HNSA.ST Hansa Biopharma AB (publ)
24.54
+10.04%
VYNE VYNE Therapeutics Inc.
1.8400
-1.08%
GUBRA.CO Gubra A/S
351.60
-2.66%
IBO Impact BioMedical Inc.
0.4258
+0.34%
ARCT Arcturus Therapeutics Holdings Inc.
12.65
+3.94%
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%